Home›Stock Screener›IOL Chemicals & Pharmaceuticals›Financial Statements

IOL Chemicals & Pharmaceuticals Complete Financial Statements

5 Years of Data
2026 - 2022

In FY2026, IOL Chemicals & Pharmaceuticals (IOLCP) reported revenue ₹621 Cr, net profit ₹53 Cr and EPS ₹1.81, with a net profit margin of 8.5% and ROE of 2.9%. Full financial statements from FY2022 to FY2026 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review IOLCP earnings multiple to evaluate earnings-based valuation against sector peers.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 8.53% 2026 data
EBITDA Margin 15.14% 2026 data
Operating Margin 15.00% 2026 data
Return on Assets 2.05% 2026 data
Return on Equity 2.95% 2026 data

Balance Sheet Ratios

Current Ratio 12.53 2026 data
Equity Ratio 69.54% 2026 data
Asset Turnover 0.24 2026 data

IOLCP Revenue, Net Profit & EBITDA — Year-on-Year Growth

IOLCP YoY (Mar 2025 vs Mar 2026) — revenue +16.7%, net profit +71.0%, EBITDA +40.3%, expenses +13.3%. Explore IOLCP fundamental worth to estimate fundamental worth using multiple valuation models.

Revenue Growth
+16.7%
Year-over-Year
Net Profit Growth
+71.0%
Year-over-Year
EBITDA Growth
+40.3%
Year-over-Year
Expense Growth
+13.3%
Year-over-Year
Assets Growth
+8.6%
Year-over-Year
Equity Growth
+6.6%
Year-over-Year
Operating Cash Flow Growth
-38.3%
Year-over-Year
Investing Cash Flow Growth
+19.4%
Year-over-Year
Financing Cash Flow Growth
+149.5%
Year-over-Year

IOLCP Income Statement — Revenue, EBITDA & Net Profit

IOL Chemicals & Pharmaceuticals revenue ₹621 Cr, EBITDA ₹94 Cr, net profit ₹53 Cr, EPS ₹1.81 (2026) — net profit margin 8.5%. For live price, earnings ratios and company overview, see IOL Chemicals & Pharmaceutical stock price NSE.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022
Revenue 621 574 532 559 586 532 511 510 527 552 596 570 529 547 579 570 530
Expenses 527 511 465 490 534 484 454 451 476 481 492 491 476 510 527 509 481
EBITDA 94 64 67 70 51 48 57 59 51 71 104 80 53 37 52 61 49
Operating Profit Margin % 15.00% 10.00% 12.00% 11.00% 8.00% 8.00% 10.00% 10.00% 9.00% 12.00% 16.00% 13.00% 9.00% 6.00% 8.00% 10.00% 8.00%
Depreciation 20 20 19 20 20 18 16 17 19 16 12 14 16 11 11 11 12
Interest 3 4 4 4 4 4 3 2 5 4 5 4 4 4 2 3 5
Profit Before Tax 71 41 45 46 28 26 37 40 28 51 87 61 32 22 39 47 33
Tax 18 11 13 12 7 7 10 10 7 13 22 15 9 6 9 12 9
Net Profit 53 30 31 34 21 19 28 30 21 38 65 46 23 16 30 35 24
Earnings Per Share (₹) 1.81 1.02 1.07 1.16 0.70 3.26 4.71 5.11 3.50 6.45 11.03 7.81 3.93 2.71 5.07 5.91 4.05

IOLCP Balance Sheet — Assets, Liabilities & Shareholders' Equity

IOLCP total assets ₹2,587 Cr, total equity ₹1,799 Cr, total liabilities ₹ Cr (2026) — ROE 2.9%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022
ASSETS
Total Assets 2,587 2,382 2,244 2,022 1,962
Current Assets 1,228 1,151 1,120 920 1,081
Fixed Assets 1,277 1,171 933 752 561
Capital Work in Progress 94 22 101 90 105
Investments 371 21 20 20 2
Other Assets 0 1,169 1,190 1,161 1,294
LIABILITIES
Total Liabilities
Current Liabilities 98 85 73 58 57
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 1,799 1,688 1,612 1,508 1,392
Share Capital 59 59 59 59 59
Reserves & Surplus 1,740 1,629 1,553 1,449 1,334

IOLCP Cash Flow Statement — Operating, Investing & Financing

IOL Chemicals & Pharmaceuticals operating cash flow ₹179 Cr, investing ₹-154 Cr, financing ₹46 Cr, net cash flow ₹71 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022
Operating Activities 179 290 122 93
Investing Activities -154 -191 -120 -121
Financing Activities 46 -93 -4 -2
Net Cash Flow 71 6 -2 -29